Back
Jefferies Financial Group Vs. Spyre Therapeutics Industry Stock Comparison
Buy
77
JEF
Jefferies Financial Group
Last Price:
62.08
Seasonality Move:
3.03%
Buy
53
SYRE
Spyre Therapeutics
Last Price:
30.15
Seasonality Move:
-4.84%
Buy
77
Jefferies Financial Group (JEF)
is a Buy
Is Jefferies Financial Group a Buy, Sell or Hold?
- The current Jefferies Financial Group [JEF] share price is $62.29. The Score for JEF is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- JEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $30.39. The Score for SYRE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JEF Stock Price Chart
What is Jefferies Financial Group's stock price today?
-
The Jefferies Financial Group share price today is $62.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JEF is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $30.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
JEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 69.77 | Buy |
| Chaikin Money Flow: | 1344120 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.72 - 59.72) | Buy |
| Bollinger Bands (100): | (46.03 - 57.25) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 60.55 | Buy |
| Chaikin Money Flow: | 253932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.52 - 29.08) | Buy |
| Bollinger Bands (100): | (25.58 - 34.28) | Buy |
JEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.05 | Buy |
| 20-day SMA: | 58.43 | Buy |
| 50-day SMA: | 56.82 | Buy |
| 200-day SMA: | 46.47 | Buy |
| 8-day EMA: | 59.79 | Buy |
| 20-day EMA: | 58.49 | Buy |
| 50-day EMA: | 56.16 | Buy |
| 200-day EMA: | 47.95 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.97 | Buy |
| 20-day SMA: | 28.07 | Buy |
| 50-day SMA: | 27.96 | Buy |
| 200-day SMA: | 29.09 | Buy |
| 8-day EMA: | 29.06 | Buy |
| 20-day EMA: | 28.34 | Buy |
| 50-day EMA: | 28.24 | Buy |
| 200-day EMA: | 27.28 | Buy |
Jefferies Financial Group Earnings Growth & JEF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.43 per share, an increase next quarter of $0.14 per share, an increase this year of $1.69 per share, and an increase next year of $1.49 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
Jefferies Financial Group Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||